These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35929377)
1. Left ventricular assist devices: A historical perspective at the intersection of medicine and engineering. Goodman D; Stulak J; Rosenbaum AN Artif Organs; 2022 Dec; 46(12):2343-2360. PubMed ID: 35929377 [TBL] [Abstract][Full Text] [Related]
2. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476 [TBL] [Abstract][Full Text] [Related]
3. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3. Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114 [TBL] [Abstract][Full Text] [Related]
4. Review of Implantable Left Ventricular Assist Devices. Tayama E; Takagi K; Shojima T; Otsuka H; Takaseya T; Arinaga K Kurume Med J; 2023 Sep; 68(3.4):171-181. PubMed ID: 37316290 [TBL] [Abstract][Full Text] [Related]
5. Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy. Malone G; Abdelsayed G; Bligh F; Al Qattan F; Syed S; Varatharajullu P; Msellati A; Mwipatayi D; Azhar M; Malone A; Fatimi SH; Conway C; Hameed A J Anat; 2023 Jan; 242(1):29-49. PubMed ID: 35445389 [TBL] [Abstract][Full Text] [Related]
6. Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device. Sidhu K; Lam PH; Mehra MR Trends Cardiovasc Med; 2020 May; 30(4):223-229. PubMed ID: 31201005 [TBL] [Abstract][Full Text] [Related]
8. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798 [TBL] [Abstract][Full Text] [Related]
9. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011. Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245 [TBL] [Abstract][Full Text] [Related]
11. Two year adverse outcomes of the magnetic levitated centrifugal continuous flow circulatory pump versus the axial continuous-flow pump for advanced heart failure: A systematic review and meta-analysis of randomized controlled trials. Tang B; Yang H Medicine (Baltimore); 2020 Feb; 99(9):e19393. PubMed ID: 32118791 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809 [TBL] [Abstract][Full Text] [Related]
13. Surgical Technique for Ventricular Device Exchange: From HeartMate II to HVAD. Gallo M; Trivedi JR; Sobieski MA; Massey TH; Cheng A; Slaughter MS ASAIO J; 2017; 63(3):364-366. PubMed ID: 28009711 [TBL] [Abstract][Full Text] [Related]
14. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948 [TBL] [Abstract][Full Text] [Related]
16. Current axial-flow devices--the HeartMate II and Jarvik 2000 left ventricular assist devices. John R Semin Thorac Cardiovasc Surg; 2008; 20(3):264-72. PubMed ID: 19038737 [TBL] [Abstract][Full Text] [Related]
17. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996 [TBL] [Abstract][Full Text] [Related]
18. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant? Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246 [TBL] [Abstract][Full Text] [Related]
19. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098 [TBL] [Abstract][Full Text] [Related]
20. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. Mehra MR; Naka Y; Uriel N; Goldstein DJ; Cleveland JC; Colombo PC; Walsh MN; Milano CA; Patel CB; Jorde UP; Pagani FD; Aaronson KD; Dean DA; McCants K; Itoh A; Ewald GA; Horstmanshof D; Long JW; Salerno C; N Engl J Med; 2017 Feb; 376(5):440-450. PubMed ID: 27959709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]